Autism Spectrum Disorder Trial, Recruiting NCT07276750 Sponsor: University of California, Los Angeles Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07276750
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a teacher (special or general education), paraeducator, speech therapist, school psychologist, or other school staff member who works directly with autistic children during the school day
  • The autistic child you work with has an official autism diagnosis documented in their school records (such as an Individualized Education Program, or IEP)
  • The child is enrolled with an educator who is participating in this trial
  • The child is in Kindergarten through 5th grade
  • The child is between 5 and 12 years old
  • The child scores 101 or higher on a behavior assessment called the SESBI-R (a tool used to measure student behavior at school)
  • The child scores 8 or higher on a separate assessment called the EDI at the start of the trial (confirm with trial site)

Who may not be able to join:

  • The child scores below 101 on the SESBI-R behavior assessment
  • The child scores below 8 on the EDI assessment at the start of the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 818-384-3554

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
30 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reported Externalizing Behavior - SESBI-R; Reported Externalizing Behavior- EDI; RUBIES Fidelity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov